Dermapharm Holding SE (DMP.DE) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of SDAX

Dermapharm Holding SE (DMP.DE) closed at EUR 38.55 on 2026-10-14, a change of +20.8 % over the past year, with a market capitalization of EUR 1.89B.

Dermapharm Holding SE recent closing prices

DateClose (EUR)
2026-10-1438.55
2026-10-1337.85
2026-10-1238.30
2026-10-0938.40
2026-10-0838.15
2026-10-0738.90
2026-10-0638.10

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Dermapharm Holding SE key figures

Previous close
EUR 38.55 (2026-10-14)
1-year change
+20.8 %
Market cap
EUR 1.89B
Enterprise value
EUR 2.85B
P/E ratio (trailing)
13.87
P/E ratio (forward)
12.86
EPS (trailing)
2.75
EPS (forward)
2.97
PEG ratio
n/a
Price to book
3.51
Revenue growth
4.8 %
Earnings growth
20.5 %
Dividend per share (trailing)
0.88
Short ratio
n/a
Employees
3,619
Analyst consensus (third-party)
none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Dermapharm Holding SE and compare it with other stocks.

Analyze DMP.DEAll SDAX stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Dermapharm Holding SE shares.